Department of Virology, PAHO/WHO Collaborating Center for Study of Dengue and its Vector, Pedro Kouri Tropical Medicine Institute, Autopista Novia del Mediodía km 6, PO Box 601, Marianao 13, Havana, Cuba.
Int J Infect Dis. 2012 Mar;16(3):e198-203. doi: 10.1016/j.ijid.2011.09.026. Epub 2012 Jan 23.
Recognizing the uniqueness of secondary dengue virus (DENV)-1/3 dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) cases at an interval of 24 years, we sought to estimate DENV infections as well as the ratios between mild disease and DHF/DSS by DENV infection sequence in Playa District (Havana, Cuba) during the 2001-2002 outbreak of dengue virus type 3 (DENV-3).
A retrospective seroepidemiological study was conducted in 2003 in Playa District. Blood samples were collected from a 1% random sample of residents and were studied for the prevalence of dengue neutralizing antibodies.
DENV-3 was found to have infected 7.2% (95% confidence interval (95% CI) 6.0-8.4%) of susceptible individuals (the entire cohort), the majority of whom experienced silent infections. Virtually every individual who had a secondary infection in the sequence DENV-1 then DENV-3 became ill, with a ratio of severe to mild cases of 1:35 (95% CI 1:67-1:23). Secondary infections in the sequence DENV-2/3 were less pathogenic than DENV-1/3. Mild disease accompanying secondary DENV2/3 occurred at a ratio of 1:4.49 infections (95% CI 1:5.77-1:3.42) secondary infections.
The results obtained highlight the role of the infecting serotype and also the sequence of the viral infection in the clinical outcome of a dengue infection.
在相隔 24 年的时间里,认识到继发登革病毒(DENV)-1/3 登革热出血热/登革休克综合征(DHF/DSS)病例的独特性,我们试图估计在 2001-2002 年登革病毒 3 型(DENV-3)爆发期间哈瓦那普拉亚区(古巴)DENV 感染以及轻度疾病与 DHF/DSS 之间的比例,通过 DENV 感染序列。
2003 年在普拉亚区进行了回顾性血清流行病学研究。采集了居民 1%的随机样本的血液样本,并研究了登革热中和抗体的流行情况。
发现 DENV-3 感染了 7.2%(95%置信区间(95%CI)为 6.0-8.4%)的易感个体(整个队列),其中大多数为无症状感染。在序列 DENV-1 然后 DENV-3 中发生继发感染的几乎每个个体都生病了,严重病例与轻度病例的比例为 1:35(95%CI 1:67-1:23)。继发于 DENV-2/3 的感染比 DENV-1/3 的致病性低。继发 DENV2/3 感染伴随的轻度疾病比例为 1:4.49 感染(95%CI 1:5.77-1:3.42)。
研究结果强调了感染血清型以及病毒感染序列在登革热感染临床结果中的作用。